SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Axonics, Inc. – ‘10-K’ for 12/31/20 – ‘EX-31.2’

On:  Monday, 3/1/21, at 4:55pm ET   ·   For:  12/31/20   ·   Accession #:  1603756-21-14   ·   File #:  1-38721

Previous ‘10-K’:  ‘10-K’ on 3/4/20 for 12/31/19   ·   Next:  ‘10-K’ on 3/1/22 for 12/31/21   ·   Latest:  ‘10-K/A’ on 4/29/24 for 12/31/23   ·   14 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/01/21  Axonics Modulation Techs, Inc.    10-K       12/31/20   80:13M

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.28M 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     47K 
 3: EX-21.1     Subsidiaries List                                   HTML     23K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     22K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
15: R1          Cover Page                                          HTML     84K 
16: R2          Consolidated Balance Sheets                         HTML    103K 
17: R3          Consolidated Balance Sheets - (Parenthetical)       HTML     42K 
18: R4          Consolidated Statements of Comprehensive Loss       HTML     87K 
19: R5          Consolidated Statements of Mezzanine Equity         HTML     39K 
20: R6          Consolidated Statements of Mezzanine Equity -       HTML     25K 
                (Parenthetical)                                                  
21: R7          Consolidated Statements of Stockholders' Equity     HTML    110K 
                (Deficit)                                                        
22: R8          Consolidated Statements of Stockholders' Equity     HTML     32K 
                (Deficit) (Parenthetical)                                        
23: R9          Consolidated Statements of Cash Flows               HTML    135K 
24: R10         Nature of Operations and Summary of Significant     HTML    105K 
                Accounting Policies                                              
25: R11         Property and Equipment                              HTML     36K 
26: R12         Intangible Asset                                    HTML     27K 
27: R13         Commitments and Contingencies                       HTML     55K 
28: R14         Long-Term Debt                                      HTML     47K 
29: R15         Stockholders' Equity                                HTML    111K 
30: R16         Noncontrolling Interest                             HTML     27K 
31: R17         Income Taxes                                        HTML     61K 
32: R18         Employee Benefit Plan                               HTML     28K 
33: R19         Related Party Transactions                          HTML     26K 
34: R20         Subsequent Events                                   HTML     27K 
35: R21         Nature of Operations and Summary of Significant     HTML    118K 
                Accounting Policies (Policies)                                   
36: R22         Nature of Operations and Summary of Significant     HTML     57K 
                Accounting Policies (Tables)                                     
37: R23         Property and Equipment (Tables)                     HTML     35K 
38: R24         Intangible Asset (Tables)                           HTML     26K 
39: R25         Commitments and Contingencies (Tables)              HTML     43K 
40: R26         Long-Term Debt (Tables)                             HTML     39K 
41: R27         Stockholders' Equity (Tables)                       HTML    103K 
42: R28         Income Taxes (Tables)                               HTML     59K 
43: R29         Nature of Operations and Summary of Significant     HTML    143K 
                Accounting Policies - Narrative (Details)                        
44: R30         Nature of Operations and Summary of Significant     HTML     32K 
                Accounting Policies - Revenue by Geographic Market               
                (Details)                                                        
45: R31         Nature of Operations and Summary of Significant     HTML     28K 
                Accounting Policies - Changes in Allowance for                   
                Doubtful Accounts (Details)                                      
46: R32         Nature of Operations and Summary of Significant     HTML     49K 
                Accounting Policies - Fair Value Hierarchy                       
                (Details)                                                        
47: R33         Property and Equipment - Summary (Details)          HTML     43K 
48: R34         Property and Equipment - Narrative (Details)        HTML     27K 
49: R35         Intangible Asset - Narrative (Details)              HTML     32K 
50: R36         Intangible Asset - Estimated Future Amortization    HTML     29K 
                Expense (Details)                                                
51: R37         Commitments and Contingencies - Narrative           HTML     88K 
                (Details)                                                        
52: R38         Commitments and Contingencies - Total Lease Cost    HTML     31K 
                (Details)                                                        
53: R39         Commitments and Contingencies - Future Minimum      HTML     46K 
                Lease Payments for Operating Lease (Details)                     
54: R40         Long-Term Debt - Narrative (Details)                HTML     72K 
55: R41         Long-Term Debt - Debt, Net of Unamortized Costs     HTML     34K 
                (Details)                                                        
56: R42         Long-Term Debt - Expected Future Principal          HTML     27K 
                Payments for Term Loan (Details)                                 
57: R43         Stockholders' Equity - Preferred Stock Narrative    HTML     35K 
                (Details)                                                        
58: R44         Stockholders' Equity - Stock-based Compensation     HTML     32K 
                Expense (Details)                                                
59: R45         Stockholders' Equity - Stock Option Narrative       HTML     45K 
                (Details)                                                        
60: R46         Stockholders' Equity - Common Stock Reserved for    HTML     40K 
                Future Issuance (Details)                                        
61: R47         Stockholders' Equity - Fair Value Assumptions       HTML     41K 
                (Details)                                                        
62: R48         Stockholders' Equity - Stock Option Activity        HTML     60K 
                (Details)                                                        
63: R49         Stockholders' Equity - Restricted Shares Award      HTML     29K 
                Narrative (Details)                                              
64: R50         Stockholders' Equity - Restricted Shares Awards     HTML     47K 
                Activity (Details)                                               
65: R51         Stockholders' Equity - Restricted Stock Units       HTML     29K 
                Narrative (Details)                                              
66: R52         Stockholders' Equity - Restricted Stock Units       HTML     47K 
                Activity (Details)                                               
67: R53         Stockholders' Equity - Stock Subscriptions          HTML     30K 
                Receivable (Details)                                             
68: R54         Stockholders' Equity - Stock Warrants (Details)     HTML     74K 
69: R55         Noncontrolling Interest - Narrative (Details)       HTML     29K 
70: R56         Income Taxes - Narrative (Details)                  HTML     47K 
71: R57         Income Taxes - Net Deferred Tax Assets (Details)    HTML     38K 
72: R58         Income Taxes - Reconciliation of Unrecognized Tax   HTML     29K 
                Benefits (Details)                                               
73: R59         Income Taxes - Effective Income Tax Rate            HTML     42K 
                Reconciliation (Details)                                         
74: R60         Employee Benefit Plan - Narrative (Details)         HTML     24K 
75: R61         Related Party Transactions - Narrative (Details)    HTML     23K 
76: R62         Subsequent Events (Details)                         HTML     51K 
78: XML         IDEA XML File -- Filing Summary                      XML    140K 
14: XML         XBRL Instance -- axnx-20201231_htm                   XML   1.65M 
77: EXCEL       IDEA Workbook of Financial Reports                  XLSX    101K 
10: EX-101.CAL  XBRL Calculations -- axnx-20201231_cal               XML    218K 
11: EX-101.DEF  XBRL Definitions -- axnx-20201231_def                XML    705K 
12: EX-101.LAB  XBRL Labels -- axnx-20201231_lab                     XML   1.64M 
13: EX-101.PRE  XBRL Presentations -- axnx-20201231_pre              XML   1.02M 
 9: EX-101.SCH  XBRL Schema -- axnx-20201231                         XSD    149K 
79: JSON        XBRL Instance as JSON Data -- MetaLinks              388±   576K 
80: ZIP         XBRL Zipped Folder -- 0001603756-21-000014-xbrl      Zip   2.33M 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Dan L. Dearen, certify that:
1.    I have reviewed this Annual Report on Form 10-K of Axonics Modulation Technologies, Inc.;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: March 1, 2021By: /s/ Dan L. Dearen
   
   
President and Chief Financial Officer
   
(Principal Financial Officer)



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/1/21
For Period end:12/31/205
 List all Filings 


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/24  Axonics, Inc.                     10-K/A     12/31/23   13:1.1M
 2/29/24  Axonics, Inc.                     10-K       12/31/23   88:24M
 3/01/23  Axonics, Inc.                     10-K       12/31/22   82:25M
 3/01/22  Axonics, Inc.                     10-K       12/31/21   79:14M
 5/13/21  Axonics, Inc.                     424B5                  1:530K
 5/11/21  Axonics, Inc.                     424B5                  1:522K
 4/30/21  Axonics, Inc.                     424B5                  1:419K
 3/03/21  Axonics, Inc.                     424B5       3/02/21    1:310K


6 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/02/20  Axonics, Inc.                     8-K:1,9    12/30/19    2:77K
 8/05/19  Axonics, Inc.                     10-Q        6/30/19   52:4.5M
 7/12/19  Axonics, Inc.                     8-K:1,9     6/28/19    2:271K
11/05/18  Axonics, Inc.                     8-K:5,8,9  11/01/18    5:143K                                   Donnelley … Solutions/FA
10/22/18  Axonics, Inc.                     S-1/A                 14:4.5M                                   Donnelley … Solutions/FA
10/05/18  Axonics, Inc.                     S-1                   39:6.7M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001603756-21-000014   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 1:58:17.3pm ET